קופגוס

Země: Izrael

Jazyk: hebrejština

Zdroj: Ministry of Health

Aktivní složka:

RIBAVIRIN 200 MG

Dostupné s:

ROCHE PHARMACEUTICALS (ISRAEL) LTD

ATC kód:

J05AB04

Léková forma:

TABLETS

Podání:

PER OS

Výrobce:

HOFFMANN LA ROCHE, SWITZERLAND

Terapeutické skupiny:

RIBAVIRIN

Terapeutické indikace:

Copegus in combination with peginterferon alfa 2a or interferon alfa - 2a is indicated in adult patients who are positive for serum HCV-RNA, including patients with compensated cirrhosis . The combination with peginterferon alfa-2a is also indicated in patients co-infected with clinically stable HIV , including patients with compensated cirrhosis . Copegus, in combination with peginterferon alfa-2a, is indicated in naive patients and patients who have failed previous treatment with interferon alpha (pegylated or non-pegylated) alone or in combination therapy with ribavirin.

Datum autorizace:

2013-04-01